ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

BACKGROUND: Drug resistance is one of the major concerns in the treatment of hepatocellular carcinoma (HCC). The aim of the present study was to determine whether aberrant high expression of the inhibitor of differentiation 1(ID1) confers oxaliplatin-resistance to HCC by activating the pentose phosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xin, Tang, Bei, Li, Jing-Huan, Wang, Yan, Zhang, Lan, Xie, Xiao-Ying, Zhang, Bo-Heng, Qiu, Shuang-Jian, Wu, Wei-Zhong, Ren, Zheng-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701377/
https://www.ncbi.nlm.nih.gov/pubmed/29169374
http://dx.doi.org/10.1186/s13046-017-0637-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701377/
https://www.ncbi.nlm.nih.gov/pubmed/29169374
http://dx.doi.org/10.1186/s13046-017-0637-7

Ejemplares similares